Quick answerMonitor suicidality, screen for bipolar history, check serotonergic interactions, and prevent abrupt or unsupervised medication changes.
Why this is correctThe medication plan must account for young-adult suicidality monitoring, activation of mania, serotonin toxicity, and discontinuation effects. Medication is one part of treatment and never replaces current safety precautions.
Easy analogy or mental pictureStarting an antidepressant is not an instant safety switch; it begins a monitored course with checkpoints for mood, behavior, interactions, and adverse effects.
Memory hookEarly SSRI care: watch mood, mania, mixing, and stopping.
NCLEX decision ruleWhen a young adult starts or changes an antidepressant, intensify monitoring and teaching; do not assume early symptom persistence means failure or add serotonergic products independently.
Why the other choices are wrongNine days does not guarantee full effect, and St. John's wort can add serotonergic interaction risk without prescriber oversight.
References
1FDA Escitalopram Capsules Prescribing InformationYoung-adult suicidality monitoring, bipolar screening, serotonin syndrome, and discontinuation precautions
2Joint Commission National Patient Safety Goal 15.01.01Validated screening, direct risk assessment, observation, environmental safety, reassessment, and discharge follow-up